|Headquarters||Dallas, Texas, United States|
|Key people||Emile A. Battat (Chairman), David A. Battat (President and CEO), Jeffery Strickland (CFO), Ronald N. Spaulding, Hugh J. Morgan, Roger F. Stebbing, John P. Stupp |
|Number of employees||11-50|
Atrion Corporation is a leading supplier of medical devices and components to niche markets in the health care and medical industry. Atrion's proprietary products, ranging from cardiovascular and ophthalmology products to fluid delivery devices, are sold to end-users, distributors and other manufacturers worldwide. . As an extension of its expertise in valve design and manufacturing, Atrion also is the leading manufacturer of valves and inflation devices for the marine and aviation markets, supplying valves used in safety products such as life vests, and inflatable boats. 
Atrion's approach to product development focuses on meeting market needs with innovative solutions
- For the cardiovascular market, Atrion introduced the MPS® Myocardial Protection System, providing the surgeon with total flexibility to continually change the mix, temperature, flow rate and precise quantities of medications delivered to the patient during open-heart surgery.
- The second generation of MPS®, introduced in 2005 as MPS2® provides several new functions including cyclic flow capability.
- For the ophthalmic market, the company manufactures the LacriCATH® balloon catheter and the device to inflate it, providing the ophthalmic surgeon with a minimally invasive means of treating blockages in tear ducts.
- In fluid delivery, Atrion's proprietary line of needle-free valves eliminates the use of needles in many routine procedures, thus protecting medical personnel against exposure to infection through accidental needle-sticks.
Top 5 Recent Tweets
|April 07, 2021||StockTexts||$ATRI Atrion Corporation SEC Filing: Form DEF 14A https://t.co/QR97xPav5A|